News Dendreon Completes Enrollment Of Phase 3 ProVent Clinical Trial Evaluating Sipuleucel-T In Men On Active Surveillance October 30, 2019Dendreon Completes Enrollment Of Phase 3 ProVent Clinical Trial Evaluating Sipuleucel-T In Men On Active SurveillanceNews Type: Press Releases